Fig. 1From: Preliminary outcomes of DEB-TACE loaded with raltitrexed in the treatment of unresectable or recurrent hepatocellular carcinomaA 68-year male treated by DEB-TACE for advanced primary HCC. A-B CT examination on admission revealed HCC and portal venous tumor emboli. C A huge tumor staining was shown and the right hepatic artery was its blood supply artery. D The right hepatic artery was embolized by 300-500 μm raltitrexed-loaded beads. E–F The tumor was found to shrink after 4 months' follow-up, but died of tumor progression 38.3 months laterBack to article page